Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats

Experimental Neurology

Volumn 184, Issue 2, 2003, Pages 1043-1052

  Shoham, S ^a   Bejar, C ^a   Kovalev, E ^a   Weinstock, M ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Cerebral glucose utilization; Demyelination; Oxidative stress; Rat; Spatial memory; Steptozotocin

Indexed keywords

STREPTOZOCIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN FORNIX; BRAIN INJURY; BRAIN SLICE; BRAIN VENTRICLE; CELL COMMUNICATION; CONTROLLED STUDY; DRUG EFFECT; EPENDYMA CELL; GLUCOSE UTILIZATION; HIPPOCAMPUS; HISTOPATHOLOGY; HYPOTHALAMUS; LATENT PERIOD; LEARNING; MALE; MAZE TEST; MEMORY; MICROGLIA; MYELINATED NERVE; MYELINATION; NERVE FIBER; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEPTUM PELLUCIDUM; SPATIAL MEMORY; SWIMMING;

EID: 0842277726     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.expneurol.2003.08.015     Document Type: Article

References (41)

1. Arnaiz E., Jelic V., Almkvist O., Wahlund L.O., Winblad B., Valind S., Nordberg A. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. NeuroReport. 12:2001;851-855.
2. Bastar I., Seckin S., Uysal M., Aykac-Toker G. Effect of streptozotocin on glutathione and lipid peroxide levels in various tissues of rats. Res. Commun. Mol. Pathol. Pharmacol. 102:1998;265-272.
3. Blokland A., Jolles J. Spatial learning deficit and reduced hippocampal ChAT activity in rats after an ICV injection of streptozotocin. Pharmacol. Biochem. Behav. 44:1993;491-494.
4. Braak H., Del Tredici K., Schultz C., Braak E. Vulnerability of select neuronal types to Alzheimer's disease. Ann. N.Y. Acad. Sci. 924:2000;53-61.
5. DeLeon M.J., Harris S.H., George A.E., Reisberg B., Christman D.R., Kricheff I.I., Wolf A.P. Computed tomography and positron emission transaxial tomography evaluation of normal aging and Alzheimer's disease. J. Cereb. Blood Flow Metab. 3:1983;391-394.
6. Duelli R., Schrock H., Kuschinsky W., Hoyer S. Intracerebroventricular injection of streptozotocin induces discrete local changes in cerebral glucose utilization in rats. Int. J. Dev. Neurosci. 12:1994;737-743.
7. Feillet-Coudray C., Rock E., Coudray C., Grzelkowska K., Azais-Braesco V., Dardevet D., Mazur A. Lipid peroxidation and antioxidant status in experimental diabetes. Clin. Chim. Acta. 284:1999;31-43.
8. Gage F.H., Kelley P.A.T., Bjorklund A. Regional changes in brain glucose metabolism reflect cognitive impairments in aged rats. J. Neurosci. 4:1984;2856-2865.
9. Galani R., Obis S., Coutureau E., Jarrard L., Cassel J.C.A. Comparison of the effects of fimbria-fornix, hippocampal, or entorhinal cortex lesions on spatial reference and working memory in rats: short versus long postsurgical recovery period. Neurobiol. Learn. Mem. 77:2002;1-16.
10. Gallyas F., Guldner F.H., Zoltay G., Wolff R. Golgi-like demonstration of "dark" neurons with an argyrophilia III method for experimental neuropathology. Acta Neuropathol. 79:1990;620-628.
11. Gerbi A., Sennoune S., Pierre S., Sampol J., Raccah D., Vague P., Maixent J.M. Localization of Na,K-ATPase alpha/beta isoforms in rat sciatic nerves: effect of diabetes and fish oil treatment. J. Neurochem. 73:1999;719-726.
12. Gibson G.E., Blass J.P. Impaired synthesis of acetylcholine in brain accompanying mild hypoxia and hypoglycaemia. J. Neurochem. 27:1976;37-42.
13. Hagg T., Fass-Holmes B., Vahlsing H.L., Manthorpe M., Conner J.M., Varon S. Nerve growth factor (NGF) reverses axotomy-induced decreases in choline acetyltransferase, NGF receptor and size of medial septum cholinergic neurons. Brain Res. 505:1989;29-38.
14. Harrell L.E., Davis J.N. Cholinergic influences on hippocampal glucose metabolism. Neuroscience. 15:1985;359-369.
15. Hellweg R., Nitsch R., Hock C., Jaksch M., Hoyer S. Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism. J. Neurosci. Res. 31:1992;479-486.
16. Hellweg R., Raivich G., Hartung H.D., Hock C., Kreutzberg G.W. Axonal transport of endogenous nerve growth factor (NGF) and NGF receptor in experimental diabetic neuropathy. Exp. Neurol. 130:1994;24-30.
17. Hoyer S., Nitsch R., Oesterreich K. Predominant abnormality in cerebral glucose utilization in late-onset dementia of the Alzheimer type: a cross-sectional comparison against advanced late-onset and incipient early-onset cases. J. Neural Transm., Parkinson's Dis. Dement. Sect. 3:1991;1-14.
18. Hoyer S., Hennenberg N., Knappm S., Lannert H., Martin E. Brain glucose metabolism is controlled by amplification and desensitization of the neuronal insulin receptor. Ann. N.Y. Acad. Sci. 777:1996;374-379.
19. Jaffey P.B., Gelman B.B. Increased vulnerability to demyelination in streptozotocin diabetic rats. Neurology. 373:1996;55-61.
20. Kiyosawa M., Baron J.C., Hamel E., Pappata S., Duverger D., Riche D., Mazoyer B., Naquet R., MacKenzie E.T. Time course of effects of unilateral lesions of the nucleus basalis of Meynert on glucose utilization by the cerebral cortex. Positron tomography in baboons. Brain. 112:1989;435-455.
21. Lannert H., Hoyer S. Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats. Behav. Neurosci. 112:1998;1199-1208.
22. Mayer G., Nitsch R., Hoyer S. Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. 532:1990;95-100.
23. Meltzer C.C., Zubieta J.K., Brandt J., Tune L.E., Mayberg H.S., Frost J.J. Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging. Neurology. 47:1996;454-461.
24. Morris R.G.M. An attempt to dissociate "spatial-mapping" and "working memory" theories of hippocampal function. Siefert W. The Neurobiology of the Hippocampus. 1983;405-432 Academic Press, London.
25. Nitsch R., Mayer G., Hoyer S. The intracerebroventricularly streptozotocin-treated rat: impairment of cerebral glucose metabolism resembles the alterations of carbohydrate metabolism of the brain in Alzheimer's disease. J. Neural Transm. 1:1989;109-110.
26. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd ed. 1986;Academic Press, San Diego.
27. Plaschke K., Hoyer S. Action of the diabetogenic drug streptozotocin on glycolytic and glycogenolytic metabolism in adult rat brain cortex and hippocampus. Int. J. Dev. Neurosci. 11:1993;477-483.
28. Prickaerts J., Fahrig T., Blokland A. Cognitive performance and biochemical markers in septum, hippocampus and striatum of rats after an i.c.v. injection of streptozotocin: a correlation analysis. Behav. Brain Res. 102:1999;73-88.
29. Reagan L.P., Magarinos A.M., Yee D.K., Swzeda L.I., Van Bueren A., McCall A.L., McEwen B.S. Oxidative stress and HNE conjugation of GLUT3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res. 862:2000;292-300.
30. Sharma M., Gupta Y.K. Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats. Pharmacol. Biochem. Behav. 70:2001;325-331.
31. Small G.W., Ercoli L.M., Silverman D.H., Huang S.C., Komo S., Bookheimer S.Y., Lavretsky H., Miller K., Siddarth Pm. , Rasgon N.L., Mazziotta J.C., Saxena S., Wu H.M., Mega M.S., Cummings J.L., Saunders A.M., Pericak-Vance M.A., Roses A.D., Barrio J.R., Phelps M.E. Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer's disease. Proc. Natl. Acad. Sci. 97:2000;6037-6042.
32. Smith K.J., Kapoor R., Felts P.A. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol. 9:1999;69-92.
33. Tan S.V., Guiloff R.J. Hypothesis on the pathogenesis of vacuolar myelopathy, dementia, and peripheral neuropathy in AIDS. J. Neurol. Neurosurg. Psychiatry. 65:1998;23-28.
34. Terwel D., Prickaerts J., Meng F., Jolles J. Brain enzyme activities after intracerebroventricular injection of streptozotocin in rats receiving acetyl-L-carnitine. Eur. J. Pharmacol. 287:1995;65-71.
35. Tsujimoto K., Tsuji N., Ozaki K., Minami M., Satoh M., Itoh N. Expression of insulin receptor-related receptor mRNA in the rat brain is highly restricted to forebrain cholinergic neurons. Neurosci. Lett. 188:1995;105-108.
36. Van Dam P.S., Van Asbeck B.S., Bravenboer B., Van Oirschot J.F., Marx J.J., Gispen W.H. Nerve conduction and antioxidant levels in experimentally diabetic rats: effects of streptozotocin dose and diabetes duration. Metabolism. 48:1999;442-447.
37. Weinstock M., Kirschenbaum-Slager N., Lazarovici P., Bejar C., Youdim M.B.H., Shoham S. Neuroprotective effects of novel cholinesterase inhibitors derived from rasagiline as potential anti-Alzheimer drugs. Ann. N.Y. Acad. Sci. 939:2001;148-161.
38. Wilson G.L., Patton N.J., McCord J.M., Mullins D.W., Mossman B.T. Mechanisms of streptozotocin and alloxan-induced damage in rat B cells. Diabetologia. 27:1984;587-591.
39. Wree A., Kaever C., Birgel B., Schleicher A., Horvath E., Zilles K. Local cerebral glucose utilization in the brain of old, learning impaired rats. Histochemistry. 95:1991;591-603.
40. Zhang L., Ino-ue M., Dong K., Yamamoto M. Retrograde axonal transport impairment of large- and medium-sized retinal ganglion cells in diabetic rat. Curr. Eye Res. 20:2000;131-136.
41. Zuvic-Butorac M., Kriz J., Simonic A., Schara M. Fluidity of the myelin sheath in the peripheral nerves of diabetic rats. Biochim. Biophys. Acta. 1537:2001;110-116.